Fikrettin Şahi̇n

ORCID: 0000-0003-1503-5567 · 2 papers in corpus

lab-animal 2026

Tissue Transglutaminase (TG2) as a Candidate Biomarker and Potential Therapeutic Target in Endometriosis: Functional Evidence from shRNA-Mediated Downregulation of TG2 in Endometrial Mesenchymal Stem Cells

Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph19101520

Background/Objectives: Endometriosis involves the presence of endometrial tissue outside the uterus. Since the migration of endometrial cells is pivotal to lesion development, tissue transglutaminase (TG2)-known for its roles in cell adhesi…

lab-animal 2026

Toward Non-Hormonal Treatment of Endometriosis: Selective Antiproliferative and Pro-Apoptotic Effects of a Boron–Curcumin–Piperine Combination on Eutopic Endometrial Cells from Women with Endometriosis

·doi:10.3390/ph19111767

Background/Objectives: Current medical treatments for endometriosis are largely hormonal and are limited by side effects and recurrence. We investigated whether a combination of sodium pentaborate pentahydrate, curcumin, and piperine select…